Precigen Receives FDA Platform Technology Designation For Adenoverse Platform
PGEN•FDA designation for Adenoverse platform
Sept. 21 (Reuters) - Precigen, Inc. (PGEN.O):
- Precigen receives FDA platform technology designation for Adenoverse platform.
PGEN•Sept. 21 (Reuters) - Precigen, Inc. (PGEN.O):
